Josh Tolkoff

Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA

BioTrove, Inc. develops, manufactures and markets systems, consisting of laboratory instruments and related consumables, for genomic analysis, high-throughput screening and molecular diagnostics. The company was founded by Tanya S. Kanigan and Colin J. H. Brenan in 2000 and is headquartered in Woburn, MA.

Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom.

Allegro Diagnostics Corp. develops and commercializes molecular diagnostics system. It focuses on lung cancer and other pulmonary diseases using proprietary gene expression technology originating within the Pulmonary Center at the Boston University School of Medicine. The company was founded by Jerome S. Brody and Avrum Spira on April 20, 2007 and is headquartered in Maynard, MA.

FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA.

Lantos Technologies, Inc. develops intra-aural 3D ear scanning systems for the custom earpiece market. Its technology enables audiologists to eliminate the uncomfortable, messy, and error-prone technique that used to generate impressions of the ear canal. The firm provides 3D scanner that measures ear canal shape and tissue compliance to produce a map of the ear canal. It also offers noise protection devices for military and industrial markets, and consumer audio earphones. The company is headquartered in Wilmington, MA.

Kaleidoscope Medical LLC develops and commercializes medical instruments. The private company is based in PARADISE VALLEY, AZ. The company was founded in 2013 by Brian J. deGuzman.

Saphena Medical, Inc. engages in the innovation and design of medical products. It offer Venapax an endoscopic vessel harvesting technology provides endoscopic vein harvesting solutions. The company was founded by Michael J. Glennon on March 6, 2014 and is headquartered in West Bridgewater, MA.

Cruzar Medsystems, Inc. manufactures houdini peripheral chronic total occlusion devices. The company is headquartered in Braintree, MA.

Lucas Associates, Inc. offers recruitment services. It also provides services like military hiring conferences and contract staffing. The company was founded by Richard M. Bruno and Arthur M. Lucas in 1970 and is headquartered in Atlanta, GA.

The Pratt & Whitney Co., Inc. designs, manufactures, and services aircraft engines and auxiliary power units. It offers commercial engine, military engine, and auxiliary power units. The company was founded by Frederick Rentschler in 1925 and is headquartered in East Hartford, CT.

Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK.

Mi3 Venture Partners Management LLC (MI3 Venture Partners) is a venture capital firm founded in 1999 by William D. McPhee. The firm is headquartered in Wellesley, Massachusetts.

Catalyst Health Ventures (Catalyst Health Ventures) is a venture capital firm founded in 2008 by Darshana Zaveri and Joshua S Phillips. The firm is Headquartered in Boston, Massachusetts.

Castel is a leading provider of customer interaction management systems for the contact center. Its full suite of solutions includes Castel Connects®, Intelligent Message Delivery™, C4™, its performance dashboard, and Digital Voice Recording. Castel Connects®, Castel's award-winning and patented customer interaction management system, consists of a set of software solutions for outbound dialing, inbound call distribution, and inbound/outbound call blending. It designed Castel Connects to work with most existing server and switching environments, and to integrate with your existing customer contact applications to fully integrate business-critical functions, such as collections, telemarketing, and customer service. Businesses across the country are currently using Castel Connects for a variety of dynamic customer contact applications, including: Collecting delinquent accounts Payment reminders Scheduling appointments Follow-up service calls Prospecting for new customers Precision marketing programs Market research Database cleansing New market development Customer surveys Its envision is a business environment where every individual responsible for working with customers, vendors or partners can utilize the powerful productivity and management capabilities of customer interaction management systems.

Pavilion Medical Innovations LLC manufactures medical devices. It develops variety of devices that are applicable in diverse healthcare markets, such as interventional cardiology and interventional radiology. The company was founded by Michael J. Glennon and Lishan Aklog and is headquartered in Norwell, MA.

BIOCIUS Life Sciences, Inc. provides medical laboratory services. The company was founded in 2009 and is headquartered in Wakefield, MA.

Rhapsody Biologics, Inc. develops a personalized peptide vaccine platform. It predicts and optimizes peptide vaccines for use at an individual and population level. Its platform technology encompasses a discovery system to identify immunogenic fragments of disease causing agents that will stimulate an immune response. The company was founded by Richard Paul Kivel and Ren Ee Chee in October 2009 and is headquartered in Norwell, MA.

Part of Medline Industries LP (Illinois), SevenOaks Biosystems LLC is a company that develops medical devices. The company is based in Cambridge, MA. The company was founded by Richard Rox Anderson, Sameer A. Sabir. SevenOaks Biosystems was acquired by Medline Industries LP (Illinois) on November 30, 2016.

Pillar Biosciences, Inc. is a clinical cancer diagnostics company. The firm engages in the creation of precision NGS panels and software solutions. It offers solid tumor panels, blood cancer panels, inherited disease panels, and custom panels. The company was founded by Gang Song and Zhaohui Wang in 2014 and is headquartered in Natick, MA.

Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA.

Conformal Medical, Inc. operates as a medical company that develops devices to prevent stroke in patient with non-valvular atrial fibrillation. The company was founded by Aaron V. Kaplan and Andy H. Levine in 2016 and is headquartered in Nashua, NH.

Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA.

Epitel, Inc. is a digital health company based in Salt Lake City, UT. Epitel, Inc. revolutionizes how brain health is monitored by combining wearable EEG technology with data analytics and machine-learning capabilities. The company designs and develop wireless solutions that provide long-term monitoring for people living with epilepsy. The company's proprietary cloud-based wearable sensor system, along with other innovative AI technologies, empowers better treatment decisions by making EEG readily deployable and accessible. Epitel's flagship product, Remi, is an unobtrusive wearable seizure detection system that records long-term EEG, providing peace of mind and better understanding for individuals managing their seizures. The company was founded by Mark Lehmkuhle and he has been the CEO since incorporation.

EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA.

Brixton Biosciences, Inc. has developed coolio™ therapy, an injection that provides long-lasting pain relief as an alternative to opioids. The company is based in Cambridge, MA and was founded by Robert M. Forrester and Sameer A. Sabir. The therapy is designed to desensitize pain in a targeted area and has the potential to eradicate the pain of pain.

OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then.

IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation.